nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Glyburide—gestational diabetes	0.603	0.729	CbGbCtD
Leflunomide—CYP2C9—Glyburide—gestational diabetes	0.224	0.271	CbGbCtD
Leflunomide—DHODH—adipose tissue—gestational diabetes	0.00938	0.138	CbGeAlD
Leflunomide—PTK2B—embryo—gestational diabetes	0.00901	0.132	CbGeAlD
Leflunomide—AHR—islet of Langerhans—gestational diabetes	0.00766	0.113	CbGeAlD
Leflunomide—DHODH—head—gestational diabetes	0.0072	0.106	CbGeAlD
Leflunomide—PTK2B—adipose tissue—gestational diabetes	0.00594	0.0873	CbGeAlD
Leflunomide—Digestion impaired—Glyburide—gestational diabetes	0.00592	0.0748	CcSEcCtD
Leflunomide—Cholestasis—Glyburide—gestational diabetes	0.00521	0.0658	CcSEcCtD
Leflunomide—AHR—uterus—gestational diabetes	0.00499	0.0734	CbGeAlD
Leflunomide—PTK2B—vagina—gestational diabetes	0.00494	0.0726	CbGeAlD
Leflunomide—AHR—adipose tissue—gestational diabetes	0.00488	0.0718	CbGeAlD
Leflunomide—PTK2B—head—gestational diabetes	0.00456	0.0671	CbGeAlD
Leflunomide—AHR—vagina—gestational diabetes	0.00406	0.0597	CbGeAlD
Leflunomide—Vasculitis—Glyburide—gestational diabetes	0.00405	0.0512	CcSEcCtD
Leflunomide—AHR—Adipogenesis—RETN—gestational diabetes	0.00332	0.13	CbGpPWpGaD
Leflunomide—Hepatic failure—Glyburide—gestational diabetes	0.0032	0.0404	CcSEcCtD
Leflunomide—Arthritis—Glyburide—gestational diabetes	0.00296	0.0373	CcSEcCtD
Leflunomide—Eosinophilia—Glyburide—gestational diabetes	0.00246	0.0311	CcSEcCtD
Leflunomide—Pancreatitis—Glyburide—gestational diabetes	0.00243	0.0308	CcSEcCtD
Leflunomide—Sweating increased—Glyburide—gestational diabetes	0.00242	0.0306	CcSEcCtD
Leflunomide—Pancytopenia—Glyburide—gestational diabetes	0.00236	0.0298	CcSEcCtD
Leflunomide—Jaundice—Glyburide—gestational diabetes	0.00216	0.0273	CcSEcCtD
Leflunomide—Agranulocytosis—Glyburide—gestational diabetes	0.00207	0.0261	CcSEcCtD
Leflunomide—Hepatitis—Glyburide—gestational diabetes	0.00199	0.0251	CcSEcCtD
Leflunomide—ABCG2—uterus—gestational diabetes	0.00194	0.0285	CbGeAlD
Leflunomide—ABCG2—adipose tissue—gestational diabetes	0.00189	0.0278	CbGeAlD
Leflunomide—Eye disorder—Glyburide—gestational diabetes	0.00186	0.0235	CcSEcCtD
Leflunomide—Alopecia—Glyburide—gestational diabetes	0.00176	0.0222	CcSEcCtD
Leflunomide—Malnutrition—Glyburide—gestational diabetes	0.00173	0.0219	CcSEcCtD
Leflunomide—Vision blurred—Glyburide—gestational diabetes	0.00163	0.0206	CcSEcCtD
Leflunomide—Anaemia—Glyburide—gestational diabetes	0.0016	0.0202	CcSEcCtD
Leflunomide—AHR—Adipogenesis—NAMPT—gestational diabetes	0.00159	0.0621	CbGpPWpGaD
Leflunomide—Angioedema—Glyburide—gestational diabetes	0.00158	0.02	CcSEcCtD
Leflunomide—ABCG2—vagina—gestational diabetes	0.00157	0.0231	CbGeAlD
Leflunomide—Leukopenia—Glyburide—gestational diabetes	0.00155	0.0196	CcSEcCtD
Leflunomide—Myalgia—Glyburide—gestational diabetes	0.00147	0.0186	CcSEcCtD
Leflunomide—Arthralgia—Glyburide—gestational diabetes	0.00147	0.0186	CcSEcCtD
Leflunomide—Nervous system disorder—Glyburide—gestational diabetes	0.00138	0.0175	CcSEcCtD
Leflunomide—Thrombocytopenia—Glyburide—gestational diabetes	0.00138	0.0175	CcSEcCtD
Leflunomide—Hyperhidrosis—Glyburide—gestational diabetes	0.00136	0.0172	CcSEcCtD
Leflunomide—Anorexia—Glyburide—gestational diabetes	0.00135	0.017	CcSEcCtD
Leflunomide—Hypotension—Glyburide—gestational diabetes	0.00132	0.0167	CcSEcCtD
Leflunomide—AHR—Adipogenesis—ADIPOQ—gestational diabetes	0.0013	0.0508	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00129	0.0163	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00128	0.0502	CbGpPWpGaD
Leflunomide—Paraesthesia—Glyburide—gestational diabetes	0.00127	0.016	CcSEcCtD
Leflunomide—Dyspnoea—Glyburide—gestational diabetes	0.00126	0.0159	CcSEcCtD
Leflunomide—Dyspepsia—Glyburide—gestational diabetes	0.00124	0.0157	CcSEcCtD
Leflunomide—Decreased appetite—Glyburide—gestational diabetes	0.00123	0.0155	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00122	0.0154	CcSEcCtD
Leflunomide—Feeling abnormal—Glyburide—gestational diabetes	0.00116	0.0147	CcSEcCtD
Leflunomide—Gastrointestinal pain—Glyburide—gestational diabetes	0.00115	0.0146	CcSEcCtD
Leflunomide—PTK2B—Coregulation of Androgen receptor activity—AR—gestational diabetes	0.00113	0.0442	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—NAMPT—gestational diabetes	0.00112	0.0438	CbGpPWpGaD
Leflunomide—Urticaria—Glyburide—gestational diabetes	0.00112	0.0142	CcSEcCtD
Leflunomide—Abdominal pain—Glyburide—gestational diabetes	0.00112	0.0141	CcSEcCtD
Leflunomide—Hypersensitivity—Glyburide—gestational diabetes	0.00104	0.0131	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.00103	0.0401	CbGpPWpGaD
Leflunomide—Asthenia—Glyburide—gestational diabetes	0.00101	0.0128	CcSEcCtD
Leflunomide—Pruritus—Glyburide—gestational diabetes	0.000999	0.0126	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000998	0.039	CbGpPWpGaD
Leflunomide—Diarrhoea—Glyburide—gestational diabetes	0.000966	0.0122	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000919	0.0359	CbGpPWpGaD
Leflunomide—Vomiting—Glyburide—gestational diabetes	0.000898	0.0113	CcSEcCtD
Leflunomide—Rash—Glyburide—gestational diabetes	0.00089	0.0112	CcSEcCtD
Leflunomide—Dermatitis—Glyburide—gestational diabetes	0.000889	0.0112	CcSEcCtD
Leflunomide—Headache—Glyburide—gestational diabetes	0.000884	0.0112	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000859	0.0335	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000859	0.0335	CbGpPWpGaD
Leflunomide—Nausea—Glyburide—gestational diabetes	0.000839	0.0106	CcSEcCtD
Leflunomide—AHR—Adipogenesis—LEP—gestational diabetes	0.000809	0.0316	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GGCT—gestational diabetes	0.000717	0.028	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000694	0.0271	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GLS2—gestational diabetes	0.000626	0.0245	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—FGF2—gestational diabetes	0.000602	0.0235	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—LEP—gestational diabetes	0.000571	0.0223	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.0005	0.0195	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—gestational diabetes	0.000421	0.0164	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—gestational diabetes	0.000374	0.0146	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000355	0.0139	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NAMPT—gestational diabetes	0.000343	0.0134	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000342	0.0134	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GCK—gestational diabetes	0.000341	0.0133	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000293	0.0114	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000292	0.0114	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000277	0.0108	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000273	0.0107	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYP19A1—gestational diabetes	0.000249	0.00974	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000236	0.00923	CbGpPWpGaD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000233	0.00911	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000224	0.00876	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000192	0.00748	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MBL2—gestational diabetes	0.000171	0.00667	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEPR—gestational diabetes	0.000145	0.00564	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000119	0.00465	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000118	0.0046	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000118	0.00459	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGCT—gestational diabetes	0.000116	0.00453	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MTNR1B—gestational diabetes	0.000114	0.00446	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RBP4—gestational diabetes	0.000111	0.00435	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000102	0.00397	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GLS2—gestational diabetes	0.000101	0.00396	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.0001	0.00392	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	9.46e-05	0.00369	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	9.46e-05	0.00369	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FGF2—gestational diabetes	5.96e-05	0.00233	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGCT—gestational diabetes	5.86e-05	0.00229	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NAMPT—gestational diabetes	5.55e-05	0.00217	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GCK—gestational diabetes	5.52e-05	0.00215	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GLS2—gestational diabetes	5.12e-05	0.002	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—gestational diabetes	5.08e-05	0.00198	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGCT—gestational diabetes	5e-05	0.00195	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.57e-05	0.00179	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GLS2—gestational diabetes	4.37e-05	0.00171	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP19A1—gestational diabetes	4.03e-05	0.00157	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.91e-05	0.00153	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGF2—gestational diabetes	3.86e-05	0.00151	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.8e-05	0.00109	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCK—gestational diabetes	2.79e-05	0.00109	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.4e-05	0.000936	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCK—gestational diabetes	2.38e-05	0.00093	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP19A1—gestational diabetes	2.04e-05	0.000795	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.74e-05	0.00068	CbGpPWpGaD
